ENZC (Enzolytics) Days Payable: 0.00 (As of Jun. 2011)


What is Enzolytics Days Payable?

Enzolytics ENZC Days Payable is 0.00 as of Jun. 2011.

Enzolytics's average Accounts Payable for the three months ended in Jun. 2011 was $0.16 Mil. Enzolytics's Cost of Goods Sold for the three months ended in Jun. 2011 was $0.00 Mil.

The historical rank and industry rank for Enzolytics's Days Payable or its related term are showing as below:

ENZC's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 113.36
* Ranked among companies with meaningful Days Payable only.

Enzolytics's Days Payable stayed the same from Jun. 2010 (0.00) to Jun. 2011 (0.00). stayed the same

Enzolytics Days Payable Historical Data

* Premium members only.

The historical data trend for Enzolytics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enzolytics Days Payable Chart

Enzolytics Annual Data
Trend Dec07 Jul08 Dec09 Dec10
Days Payable
0.00 0.00 0.00 0.00

Enzolytics Quarterly Data
Sep07 Dec07 Apr08 Jul08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Enzolytics Days Payable Competitor Comparison

For the Biotechnology subindustry, Enzolytics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Enzolytics Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Enzolytics's Days Payable distribution charts can be found below:

* The bar in red indicates where Enzolytics's Days Payable falls into.


Enzolytics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Enzolytics's Days Payable for the fiscal year that ended in Dec. 2010 is calculated as

Days Payable (A: Dec. 2010 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2009 ) + Accounts Payable (A: Dec. 2010 )) / count ) / Cost of Goods Sold (A: Dec. 2010 )*Days in Period
=( (0.134 + 0.162) / 2 ) / 0*365
=0.148 / 0*365
=N/A

Enzolytics's Days Payable for the quarter that ended in Jun. 2011 is calculated as:

Days Payable (Q: Jun. 2011 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Mar. 2011 ) + Accounts Payable (Q: Jun. 2011 )) / count ) / Cost of Goods Sold (Q: Jun. 2011 )*Days in Period
=( (0.16 + 0.16) / 2 ) / 0*365 / 4
=0.16 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Enzolytics (ENZC) has a Days Payable of 0.00 as of Jun. 2011. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Enzolytics and its competitors.
Is Enzolytics' Days Payable too high?
Enzolytics' current Days Payable is 0.00.
How does Enzolytics' Days Payable compare to competitors?
Enzolytics' Days Payable of 0.00 can be compared against companies in the Biotechnology industry. The industry median Days Payable is 113.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.36, based on 705 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Enzolytics and its competitors. For the Biotechnology industry, the median Days Payable is 113.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Enzolytics's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enzolytics stock overvalued right now?
Enzolytics (ENZC) has a current Days Payable of 0.00. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Enzolytics (ENZC), the current Days Payable is 0.00 as of Jun. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Enzolytics Business Description

Address 1101 Raintree Circle, Suite 130, Allen, TX, USA, 75013
Enzolytics Inc is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The company is committed to creating drugs for the good health of mankind. ENZC's flagship compound, ITV-1, is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use.